基本信息
浏览量:316
职业迁徙
个人简介
Dr Michihiko Kuwano is professor and director at Research
Center for Innovative Cancer Therapy at Kurume University,
Kurume, Fukuoka, Japan. At present, his focus is on the
establishment of molecular targets that could be closely
associated with drug resistance and other malignant
characteristics in cancer cells and their micro-environments
in tumor stroma. These molecular targets will be intrinsically
important to development of novel and useful therapeutic
strategies that could be great help for cancer patients.
Dr Kuwano graduated from Kyushu University School
of Medicine (M.D.) in 1964. He had already started his
research career in molecular biology of bacteria and bacteriophage
when he was a medical student. He received his Ph.D.
on genetics on ribosomes by analysis of bacterial antibioticsresistant
mutants at Medical Institute of Bioregulation, Kyushu
University (Professor Hideya Endo). Based on this molecular
biology study with bacterial mutants, he further continued
bacterial molecular biology research on protein synthesis and
mRNA degradation during postdoctoral fellowship at
Department of Microbiology and Immunology, Washington
University School of Medicine (St. Louis) (Professor David
Schlessinger) (1969-1971), and at the Medical Institute of
Bioregulation, Kyushu University (1971-1978).
研究兴趣
论文共 325 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Research Square (Research Square) (2023)
引用0浏览0引用
0
0
crossref(2023)
crossref(2023)
CANCER SCIENCE (2023): 1261-1261
引用0浏览0引用
0
0
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
The Kurume medical journalno. 1.2 (2023): 39-46
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn